Global Cephalosporin Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of 14.4% –

DUBLIN–(BUSINESS WIRE)–The “Cephalosporin
Market by Generation, Type, Route of Drug Administration, and
Application – Global Opportunity Analysis and Industry Forecast,
report has been added to’s

The global cephalosporin market is estimated to reach $1,99,754 million
by 2023 from $77,764 million in 2016, growing at a CAGR of 14.4% from
2017 to 2023.

Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics,
which is majorly used to treat bacterial infections. It resembles
penicillin and hence is used as an alternative for patients who are
allergic to penicillin. It is used in the treatment of a variety of
clinical conditions, including pneumonia, skin infections, strep throat,
staph infections, tonsillitis, bronchitis, otitis media, and gonorrhea.

The major factors that contribute to the growth of the cephalosporin
market include increase in R&D activities to develop highly efficient &
safe drugs; upsurge in use of combination therapies; and rise in
incidence of pneumonia, tonsillitis, bronchitis, and gonorrhea.
Moreover, increased approvals of drugs and growth in awareness about
various infections & antibiotic resistance propel the market growth.

The global cephalosporin market is segmented on the basis of generation,
type, route of drug administration, application, and region. Based on
generation, the market is divided into first-generation cephalosporin,
second-generation cephalosporin, third-generation cephalosporin,
fourth-generation cephalosporin, and fifth-generation cephalosporin. By
type, it is bifurcated into branded and generics.

Depending on route of drug administration, it is classified into
injection and oral. The applications covered in the study include
respiratory tract infection, skin infection, ear infection, urinary
tract infection, sexually transmitted infection, and others.

Companies Mentioned:

  • Allergan Plc
  • Bristol-Myers Squibb Company
  • Lupin Limited
  • Sanofi
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Cephalosporin Market, by Generation

5 Cephalosporin Market, by Type

6 Cephalosporin Market, by Route of Drug Administration

7 Cephalosporin Market, by Application

8 Cephalosporin Market, by Region

9 Company Profiles

For more information about this report visit

Laura Wood, Senior Manager
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Topics: Antibiotics